4//SEC Filing
Kollins John A 4
Accession 0001181431-13-002493
CIK 0001178711other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 7:00 PM ET
Size
10.1 KB
Accession
0001181431-13-002493
Insider Transaction Report
Form 4
Kollins John A
SVP, Chief Business Officer
Transactions
- Award
Common Stock Option (right to buy)
2013-01-07+90,000→ 90,000 totalExercise: $5.40Exp: 2023-01-07→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The option vests in forty-eight equal monthly installments beginning on February 7, 2013.
Issuer
Transcept Pharmaceuticals Inc
CIK 0001178711
Entity typeother
Related Parties
1- filerCIK 0001391070
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 7:00 PM ET
- Size
- 10.1 KB